TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Top Cited Papers
- 1 April 2006
- journal article
- review article
- Published by Annual Reviews in Annual Review of Immunology
- Vol. 24 (1), 99-146
- https://doi.org/10.1146/annurev.immunol.24.021605.090737
Abstract
Transforming growth factor-beta (TGF-beta) is a potent regulatory cytokine with diverse effects on hemopoietic cells. The pivotal function of TGF-beta in the immune system is to maintain tolerance via the regulation of lymphocyte proliferation, differentiation, and survival. In addition, TGF-beta controls the initiation and resolution of inflammatory responses through the regulation of chemotaxis, activation, and survival of lymphocytes, natural killer cells, dendritic cells, macrophages, mast cells, and granulocytes. The regulatory activity of TGF-beta is modulated by the cell differentiation state and by the presence of inflammatory cytokines and costimulatory molecules. Collectively, TGF-beta inhibits the development of immunopathology to self or nonharmful antigens without compromising immune responses to pathogens. This review highlights the findings that have advanced our understanding of TGF-beta in the immune system and in disease.Keywords
This publication has 378 references indexed in Scilit:
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- New insights into TGF-β–Smad signallingTrends in Biochemical Sciences, 2004
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Inflammation in atherosclerosisNature, 2002
- Innate and acquired immunity in atherogenesisNature Medicine, 2002
- Transforming growth factor-β in T-cell biologyNature Reviews Immunology, 2002
- The TGFβ Receptor Activation ProcessMolecular Cell, 2001
- Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.Journal of Clinical Investigation, 1998
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992